Specific niche view of the structured sector hierarchy. Useful for precedent work where broader sector slices include too much noise.
| Target | Buyer / Investor | Sector | Geo | Transaction size | EV / EBITDA |
|---|---|---|---|---|---|
| Orchestra Bio | OpenAI | Biotechnology & Medical Research (NEC) | $52.0M – $68.0M | n/m | |
| Bio-Techne | Merck KGaA | Biotechnology & Medical Research (NEC) | $11,300M | n/m | |
| Solaria Bio | Viome | Biotechnology & Medical Research (NEC) | $38.2M – $51.7M | n/m | |
| CliniQuantum | NeuroThera Labs Inc | Biotechnology & Medical Research (NEC) | $7.0M | n/m | |
| Vegamour, LLC | Belle Brands, Windsong Global | Biotechnology & Medical Research (NEC) | $31.0M – $42.0M | 5× – 7× | |
| CRS Clinical Research Services Berlin GmbH | hVIVO Plc | Biotechnology & Medical Research (NEC) | $24.2M – $32.8M | 8× – 11× | |
| Biorbyt Ltd. | AVS Bio, Arlington Capital Partners | Biotechnology & Medical Research (NEC) | $43.0M – $58.0M | 7× – 9× | |
| Coefficient Bio | Anthropic | Biotechnology & Medical Research (NEC) | $65.0M – $88.0M | 6× – 8× | |
| Early Phase Services division of Worldwide Clinical Trials | Fortrea | Biotechnology & Medical Research (NEC) | $45.0M | 5× – 7× | |
| Bio-Techne Corp. | Merck KGaA | Biotechnology & Medical Research (NEC) | $4,960M – $6,710M | 15× – 20× |
Bins are observed deal frequencies across disclosed transactions. Use as a directional reference, not a target valuation.
Use the directory on the recent deals hub to switch between countries, sectors and sub-sectors. A free account unlocks the structured filters that go beyond the public view.